Stem Cell's Leukemia Drug Gains Orphan Status

Nov 07, 2013

PMlive.com

Tigecycline is being investigated by Stem Cell Therapeutics for its use in the treatment of acute myeloid leukaemia (AML), a type of cancer that affects a patient's blood and bone marrow. There were just under 15,000 new cases of the disease reported in the US in 2013 and more than 10,000 deaths. Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments